Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Condition(s):Prader-Willi Syndrome; HyperphagiaLast Updated:February 17, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Prader-Willi Syndrome; HyperphagiaLast Updated:February 17, 2021Terminated
Condition(s):Prader-Willi Syndrome; ObesityLast Updated:September 22, 2014Completed
Condition(s):Prader-Willi SyndromeLast Updated:August 1, 2023Terminated
Condition(s):Prader-Willi SyndromeLast Updated:August 25, 2022Completed
Condition(s):Prader-Willi SyndromeLast Updated:February 28, 2019Unknown status
Condition(s):Prader-Willi SyndromeLast Updated:August 9, 2023Completed
Condition(s):Prader-Willi SyndromeLast Updated:September 13, 2022Recruiting
Condition(s):Prader-Willi Syndrome; ObesityLast Updated:April 12, 2023Recruiting
Condition(s):Prader-Willi Syndrome; Growth Hormone DeficiencyLast Updated:September 24, 2021Completed
Condition(s):Angelman Syndrome; Prader-Willi SyndromeLast Updated:September 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.